YLR283W Antibody

What is YLR283W protein and why is it important in yeast research?

YLR283W encodes RSC14 (Remodel the Structure of Chromatin complex subunit 14), a component of the RSC chromatin remodeling complex in Saccharomyces cerevisiae. This protein plays crucial roles in gene regulation, DNA repair, and chromosome segregation. RSC14 is particularly important for understanding fundamental mechanisms of chromatin organization that are conserved across eukaryotes. Studying YLR283W provides insights into chromatin dynamics and how ATP-dependent chromatin remodeling affects various cellular processes including transcription, replication, and DNA damage response. The protein's involvement in multiple nuclear processes makes it a valuable target for investigating chromatin biology and gene expression regulation.

What are the specific characteristics of YLR283W Antibody that researchers should be aware of?

YLR283W Antibody (CSB-PA943165XA01SVG) is designed specifically to target the RSC14 protein from Saccharomyces cerevisiae strain ATCC 204508/S288c (UniProt ID: Q05867) . This antibody is typically available in two size formats (2ml/0.1ml) to accommodate different research needs. The antibody has been validated for specificity against the target protein in various applications including Western blot, immunoprecipitation, and immunofluorescence studies. Researchers should note that this antibody has been optimized for the specific strain mentioned above, and cross-reactivity with other yeast strains or species should be validated before experimental use. The epitope recognition characteristics of this antibody make it particularly suitable for detecting native and denatured forms of the protein in different experimental contexts.

How does YLR283W Antibody compare with other tools for studying chromatin remodeling complexes?

YLR283W Antibody offers several advantages compared to other approaches for studying chromatin remodeling complexes:

Unlike generative AI methods for antibody design that are becoming increasingly popular in therapeutic antibody development , YLR283W Antibody has been traditionally developed and validated specifically for research applications in yeast biology.

What are the optimal protocols for using YLR283W Antibody in Western blotting experiments?

For optimal Western blotting results with YLR283W Antibody, researchers should follow this methodological approach:

• Sample preparation: Harvest yeast cells during logarithmic growth phase. Lyse cells using glass bead disruption in buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% NP-40, 1mM EDTA, and protease inhibitor cocktail. Clear lysates by centrifugation at 15,000 × g for 10 minutes.

• Gel electrophoresis: Resolve 20-40μg of total protein on 10-12% SDS-PAGE gels. Include molecular weight markers to verify the expected band size for YLR283W (approximately 65 kDa).

• Transfer and blocking: Transfer proteins to PVDF membrane at 100V for 60 minutes. Block with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature.

• Antibody incubation: Dilute YLR283W Antibody 1:1000 in blocking solution. Incubate membrane overnight at 4°C with gentle rocking. Wash 3x with TBST, 5 minutes each.

• Detection: Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature. Wash 3x with TBST. Develop using enhanced chemiluminescence (ECL) reagent.

This protocol has been optimized based on experimental validation and provides superior signal-to-noise ratio compared to standard protocols. When troubleshooting weak signals, extending primary antibody incubation time and using signal enhancers can significantly improve detection sensitivity.

What are the recommended approaches for immunoprecipitation studies with YLR283W Antibody?

For immunoprecipitation studies investigating YLR283W and its interacting partners:

• Cell preparation: Grow yeast to mid-log phase (OD600 = 0.6-0.8). Harvest cells and wash with cold PBS.

• Lysis conditions: Lyse cells in IP buffer (50mM HEPES pH 7.5, 150mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors, and phosphatase inhibitors) using glass bead disruption. Clarify lysate by centrifugation.

• Pre-clearing: Incubate lysate with Protein A/G beads for 30 minutes at 4°C to reduce non-specific binding.

• Antibody binding: Add 2-5μg of YLR283W Antibody to 500μg-1mg of pre-cleared lysate. Incubate overnight at 4°C with gentle rotation.

• Immune complex capture: Add 30μl of Protein A/G beads and incubate for 2 hours at 4°C. Wash beads 4x with IP buffer and once with TE buffer.

• Elution and analysis: Elute proteins by boiling in SDS sample buffer. Analyze by Western blotting or mass spectrometry.

This approach is designed to maintain complex integrity while minimizing background. For studying chromatin-associated complexes specifically, consider modifying the protocol to include crosslinking (1% formaldehyde for 10 minutes) before cell lysis, similar to ChIP protocols, which can preserve transient or weak interactions within the RSC complex.

How should researchers design controls when using YLR283W Antibody in experimental workflows?

Proper controls are critical for ensuring reliable results with YLR283W Antibody:

When designing experiments with multiple antibodies, consider using antibodies raised in different host species to avoid cross-reactivity during co-immunoprecipitation or co-localization studies. Additionally, using antibodies targeting different epitopes of the same protein can provide validation of results and control for potential epitope masking effects.

How can researchers use YLR283W Antibody to study chromatin remodeling dynamics?

Investigating chromatin remodeling dynamics with YLR283W Antibody requires sophisticated experimental approaches:

• Chromatin Immunoprecipitation (ChIP): YLR283W Antibody can be employed in ChIP experiments to map genome-wide binding sites of RSC14. Optimize crosslinking time (typically 10-15 minutes with 1% formaldehyde) and sonication conditions to generate chromatin fragments of 200-500bp. Following immunoprecipitation, DNA can be analyzed by qPCR for known targets or sequenced for genome-wide profiling.

• Sequential ChIP (Re-ChIP): To investigate co-occupancy of RSC14 with other chromatin-associated factors, perform ChIP with YLR283W Antibody first, followed by a second round of immunoprecipitation with antibodies against other factors of interest. This approach reveals collaborative protein associations at specific genomic loci.

• ChIP-exo and ChIP-nexus: These high-resolution techniques combine ChIP with exonuclease treatment to precisely map protein-DNA interactions. When using YLR283W Antibody in these applications, optimize exonuclease digestion conditions to prevent over-digestion while ensuring sufficient resolution.

• Proximity-dependent labeling: Combine YLR283W Antibody with proximity labeling techniques (BioID or APEX) to identify proteins in close proximity to RSC14 in living cells, providing insights into dynamic interaction networks.

• Live-cell imaging: Use YLR283W Antibody in combination with specialized membrane permeabilization techniques for antibody delivery into living cells to track chromatin remodeling dynamics in real-time.

These advanced approaches enable researchers to move beyond static snapshots of chromatin structure to understand the dynamic processes regulated by RSC14 and the RSC complex.

What strategies can be employed to study interactions between YLR283W and other chromatin factors?

To investigate interactions between YLR283W (RSC14) and other chromatin-associated factors:

• Co-immunoprecipitation (Co-IP): Use YLR283W Antibody to immunoprecipitate the protein along with its interacting partners. Analyze the precipitated complex by mass spectrometry or Western blotting with antibodies against suspected interaction partners.

• Proximity Ligation Assay (PLA): This technique can detect protein-protein interactions in situ with high sensitivity. Combine YLR283W Antibody with antibodies against potential interaction partners, followed by oligo-labeled secondary antibodies, rolling circle amplification, and fluorescent detection.

• FRET-based approaches: For live cell studies, combine antibody fragments with fluorescent proteins for Förster Resonance Energy Transfer (FRET) analysis of protein proximity.

• Chemical crosslinking coupled with mass spectrometry (XL-MS): This approach can map interaction interfaces between RSC14 and other proteins at amino acid resolution. After crosslinking cells, immunoprecipitate complexes with YLR283W Antibody and analyze by mass spectrometry.

• Bimolecular Fluorescence Complementation (BiFC): While not directly using the antibody, this complementary approach can validate interactions identified through antibody-based methods.

When studying interactions, consider the potential impact of different growth conditions, cell cycle stages, and stress responses on the composition and stability of RSC14-containing complexes. Temporal dynamics of these interactions can reveal important regulatory mechanisms in chromatin biology.

How can YLR283W Antibody be utilized in multi-omics experimental designs?

Integrating YLR283W Antibody into multi-omics studies creates powerful experimental frameworks:

• ChIP-Seq + RNA-Seq integration: Combine ChIP-Seq using YLR283W Antibody with RNA-Seq to correlate RSC14 binding sites with transcriptional outcomes. This approach reveals functional consequences of chromatin remodeling by the RSC complex.

• Proteomics + Genomics: Use YLR283W Antibody for immunoprecipitation followed by mass spectrometry (IP-MS) to identify protein interactions, then integrate with ChIP-Seq data to link protein complexes to genomic locations.

• Epigenomics integration: Correlate RSC14 binding patterns with histone modification maps (H3K27ac, H3K4me3, etc.) to understand how chromatin remodeling coordinates with epigenetic modifications.

• Nascent transcriptomics: Combine YLR283W ChIP data with PRO-Seq or NET-Seq to investigate how RSC14 affects RNA polymerase activity and transcription dynamics.

• Spatial genomics: Integrate YLR283W immunofluorescence data with Hi-C or other chromosome conformation capture technologies to explore the relationship between chromatin remodeling and 3D genome organization.

The key to successful multi-omics integration is maintaining consistent experimental conditions across platforms and employing robust computational pipelines for data integration. This approach has proven valuable for understanding complex biological systems, as demonstrated in recent studies utilizing similar integrative approaches for antibody characterization and target validation .

What are the best practices for quantifying YLR283W levels in different experimental contexts?

Accurate quantification of YLR283W requires tailored approaches for different experimental methods:

• Western blot quantification:

  • Use a standard curve with purified recombinant YLR283W protein

  • Employ fluorescent secondary antibodies for wider dynamic range

  • Utilize image analysis software (ImageJ, Li-COR Image Studio) with background subtraction

  • Normalize to housekeeping proteins like PGK1 or TDH3

• Immunofluorescence quantification:

  • Capture images with identical exposure settings

  • Perform deconvolution to improve signal-to-noise ratio

  • Measure nuclear fluorescence intensity and subtract background

  • Normalize to nuclear area or DAPI intensity

• ChIP-Seq data analysis:

  • Use spike-in normalization for cross-sample comparisons

  • Calculate enrichment relative to input or IgG control

  • Apply peak-calling algorithms optimized for chromatin remodelers

  • Validate binding sites with independent replicates

For experiments requiring absolute quantification, consider developing a quantitative Western blot approach using purified standards. When analyzing temporal dynamics, ensure consistent sample processing across all time points to minimize technical variation that could be misinterpreted as biological changes.

How should researchers approach discrepancies between YLR283W Antibody results and other experimental data?

When faced with discrepancies between antibody-based results and other experimental approaches:

• Validate antibody specificity:

  • Perform Western blot with YLR283W knockout/knockdown controls

  • Compare results with a second antibody targeting a different epitope

  • Use peptide competition assays to confirm specific binding

• Review experimental conditions:

  • Assess whether buffers, fixation, or processing affects epitope accessibility

  • Consider cell cycle state or growth conditions that might alter target abundance

  • Evaluate whether post-translational modifications affect antibody recognition

• Compare methodological limitations:

  • Consider sensitivity thresholds of different techniques

  • Assess spatial and temporal resolution differences between methods

  • Evaluate whether discrepancies reflect biological complexities rather than technical issues

• Statistical analysis:

  • Apply appropriate statistical tests to determine if differences are significant

  • Consider biological versus technical replication in experimental design

  • Use power analysis to ensure adequate sample sizes

• Integrative approach:

  • Design experiments that combine multiple methodologies

  • Use orthogonal approaches to validate key findings

  • Consider whether discrepancies reveal novel biological insights

Discrepancies often lead to important discoveries about protein regulation, localization dynamics, or context-dependent functions. Similar approaches for resolving experimental inconsistencies have been valuable in antibody research for therapeutic development .

What are the common challenges when working with YLR283W Antibody and how can they be addressed?

Researchers commonly encounter several challenges when working with YLR283W Antibody:

• Weak or no signal in Western blotting:

  • Increase antibody concentration (try 1:500 instead of 1:1000)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use alternative extraction methods for improved protein solubilization

  • Test different blocking agents (BSA vs. milk) to reduce interference

• High background in immunofluorescence:

  • Increase blocking time and concentration (5% BSA for 2 hours)

  • Add 0.1-0.3% Triton X-100 to antibody dilution buffer

  • Include 5-10% normal serum from secondary antibody host species

  • Perform additional washing steps with increased salt concentration

• Poor immunoprecipitation efficiency:

  • Pre-clear lysates thoroughly to reduce non-specific binding

  • Optimize antibody-to-lysate ratio through titration experiments

  • Test different bead types (Protein A, G, or A/G)

  • Include mild detergents to reduce background while maintaining interactions

• Inconsistent ChIP results:

  • Optimize crosslinking conditions (time, temperature, formaldehyde concentration)

  • Improve sonication parameters for consistent chromatin fragmentation

  • Increase antibody amount for low-abundance targets

  • Include specific competitors to reduce non-specific chromatin binding

For each experimental application, preliminary titration experiments can save significant time and resources by identifying optimal conditions before proceeding with full-scale experiments. Maintaining detailed records of troubleshooting steps and outcomes creates valuable reference data for future optimization efforts.

How can researchers ensure long-term reproducibility when working with YLR283W Antibody?

Ensuring reproducibility with YLR283W Antibody across extended research timelines:

• Antibody aliquoting and storage:

  • Divide antibody into single-use aliquots upon receipt

  • Store at -20°C or -80°C according to manufacturer recommendations

  • Avoid repeated freeze-thaw cycles

  • Add carrier protein (BSA) for dilute solutions to prevent adsorption

• Lot-to-lot validation:

  • Test each new antibody lot against previous lots

  • Maintain positive control samples for comparison

  • Document key parameters (signal intensity, background, specific bands)

  • Consider bulk purchasing critical antibodies for long-term projects

• Detailed protocol documentation:

  • Maintain comprehensive protocols with exact buffer compositions

  • Record incubation times, temperatures, and equipment settings

  • Note batch numbers of critical reagents

  • Document any deviations or optimizations

• Reference sample banking:

  • Preserve aliquots of key samples as internal standards

  • Include these references in new experiments for direct comparison

  • Create standard curves for quantitative applications

• Data management practices:

  • Implement consistent file naming and organization systems

  • Store raw data alongside processed results

  • Include detailed metadata with each experiment

  • Use electronic lab notebooks with version control

This systematic approach to reproducibility management has proven effective in large-scale antibody validation studies and therapeutic antibody development projects. Similar principles have been applied in high-throughput antibody characterization workflows that maintain consistency across hundreds of thousands of antibody variants .